TABLE 1
FROM:
Marketing Economics
Pricing and reimbursement: Towards a holistic approach
Yorn Schmidt and Roman Rittweger
BACK TO ARTICLETable 1. Key drivers for determining a coherent reimbursement strategy
| Category | Key drivers | Variables for input model* |
|---|---|---|
| Regulatory requirements | ||
Regulatory framework | ||
Payor infrastructure | ||
Governmental | N | |
Autonomous price committees | ||
| Commercial setting | ||
Market size | P | |
Individual country market potential/market share estimate | P | |
Lifecycle | P | |
Competition/comp. pricing | P | |
Expected product USP | N | |
Supply chain (threat of parallel trade, dilution of retail market by hospital supply) | N | |
| Clinical and pharmacoeconomic value | ||
Innovation vs me-too | N | |
Availability of outcomes model | N | |
Clinical evidence | N/P | |
Guideline compliance | N | |
| Health care setting | ||
National and regional health care framework | N | |
Purchasing networks | N | |
Hospital vs retail infrastructure | N | |
Allocation of additional budgets | N | |
* P, parametric; N, non-parametric.
Regulatory framework
Payor infrastructure